IL-6-soluble IL-6 receptor complex inhibits the proliferation of dermal fibroblasts

International Journal of Immunopharmacology

Volumn 18, Issue 1, 1996, Pages 89-94

  Mihara, Masahiko ^a   Moriya, Yoichiro ^a   Ohsugi, Yoshiyuki ^a  

^a CHUGAI PHARMACEUTICAL CO LTD   (Japan)

Author keywords

dermal fibroblast; IL 6; proliferation; soluble IL 6 receptor

Indexed keywords

CYTOKINE RECEPTOR; RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT INTERLEUKIN 6; RECOMBINANT PLATELET DERIVED GROWTH FACTOR; RECOMBINANT TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL PROLIFERATION; FIBROBLAST; HUMAN; HUMAN CELL; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SYSTEMIC SCLEROSIS;

EID: 0029930901     PISSN: 01920561     EISSN: None     Source Type: Journal    
DOI: 10.1016/0192-0561(95)00106-9     Document Type: Article

References (20)

1. Akira, S., Taga, T. & Kishimoto, T. (1993). Interleukin-6 in biology and medicine. Adv. Immun., 54, 1-78.
2. Chen, L., Mory, Y., Zilberstein, A. & Revel, M. (1988). Growth inhibition of human breast carcinoma and leukemia/lymphoma cell lines by recombinant interferon β2. Proc. natn. Acad. Sci. U.S.A., 85, 8037-8041.
3. Clemmons, D. R. & Van Wyk, J. J. (1981). Somatomedin-C and platelet-derived growth factor stimulate human fibroblast replication. J. cell. Physiol., 106, 361-367.
4. Crestani, B., Seta, N., De Bandt, M., Soler, P., Rolland, C., Dehoux, M., Boutten, A., Dombret, M.-C., Palazzo, E., Kahn, M.-F. & Aubier, M. (1994). Interleukin-6 secretion by monocytes and alveolar macrophages in systemic screlosis with lung involvement. Am. J. resp. Crit. Care. Med., 149, 1260-1265.
5. Feghali, C. A., Bost, K. L., Boulware, D. W. & Levy, L. S. (1992). Mechanisms of pathogenesis in scleroderma. I. Overproduction of interleukin-6 by fibroblasts cultured from affected skin sites of patients with scleroderma. J. Rheumatol., 19, 1207-1211.
6. Gruschwitz, M., Muller, P. U., Sepp, N., Hofer, E., Fontana, A. & Wick, G. (1990). Transcription and expression of transforming growth factor type beta in the skin of progressive systemic sclerosis: a mediator of fibrosis? J. invest. Dermatol., 94, 197-203.
7. Hirata, Y., Taga, T., Hibi, M., Nakano, N., Hirano, T. & Kishimoto, T. (1989). Characterization of IL-6 receptor expression by monoclonal and polyclonal antibodies. J. Immun., 143, 2900-2906.
8. Honda, M., Yamamoto, S., Cheng, M., Yasukawa, K., Suzuki, H., Saito, T., Ohsugi, Y., Tokunaga, T. & Kishimoto, T. (1992). Human soluble IL-6 receptor: its detection and enhanced release by HIV infection. J. Immun., 148, 2175-2180.
9. Kahaleh, M. B. & Yin, T. G. (1992). Enhanced expression of high-affinity interleukin-2 receptors in scleroderma: possible role for IL-6. Clin. Immun. Immunopath., 62, 97-102.
10. Kawaguchi, Y. (1994). IL-1 alpha gene expression and protein production by fibroblasts from patients with systemic sclerosis. Clin. exp. Immun., 97, 445-450.
11. Koch, A. E., Kronfeld-Harrington, L. B., Szekanecz, Z., Cho, M. M., Haines, G. K., Harlow, L. A., Strieter, R. M., Kunkel, S. L., Massa, M. C., Barr, W. G. & Jimenez, S. A. (1993). In situ expression of cytokines and cellular adhesion molecules in the skin of patients with systemic sclerosis. Their role in early and late disease. Pathobiology, 61, 239-246.
12. Matsuda, T., Hirano, T. & Kishimoto, T. (1988). Establishment of an interleukin-6 (IL-6)/B-cell stimulatory factor 2-dependent cell line and preparation of anti-IL-6 monoclonal antibodies. Eur. J. Immun., 18, 951-956.
13. Mihara, M., Moriya, Y. & Ohsugi, Y. (1995). IL-6 induces the proliferation of synovial fibroblastic cells in the presence of soluble IL-6 receptor. Br. J. Rheumatol., 34, 321-325.
14. Schikdler, R., Mancilla, J., Endres, S., Ghorbani, R., Clark, S. C. & Dinarello, A. (1990). Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood, 75, 40-47.
15. Schmidt, J. A., Mizel, S. B., Cohen, D. & Green, I. (1982). Interleukin-1, a potential regulator of fibroblast proliferation. J. Immun., 128, 2177-2182.
16. Sporn, M. B. & Roberts, A. B. (1989). Transforming growth factor β: multiple actions and potential clinical applications. J. Am. med. Assoc., 262, 938-948.
17. Taga, T., Hibi, M., Hirata, Y., Yamazaki, K., Yasukawa, K., Matsuda, T., Hirano, T. & Kishimoto, T. (1989). Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130. Cell, 58, 573-581.
18. Vilcek, J., Palombella, V. J., Henriksen-Destefano, D., Swenson, C., Feinman, R., Hirai, M. & Tsujimoto, M. (1986). Fibroblast growth enhancing activity of tumor necrosis factor and its relationship to other polypeptide growth factors. J. exp. Med., 163, 632-643.
19. Yamakage, A., Kikuchi, K., Smith, E. A., Leroy, E. C. & Trojanowska, M. (1992). Selective upregulation of platelet-derived growth factor alpha receptors by transforming growth factor beta in scleroderma fibroblast. J. exp. Med., 175, 1227-1234.
20. Yasukawa, K., Saito, T., Fukunaga, T., Sekimori, Y., Koishihara, Y., Fukui, H., Ohsugi, Y., Matsuda, T., Yawata, H., Hirano, T., Taga, T. & Kishimoto, T. (1990). Purification and characterization of soluble human IL-6 receptor expressed in CHO cells. J. Biochem., 108, 673-676.